Project Grant R37CA296615
Award Date
1/15/25
Completion Date
12/31/29
Dollars Obligated
$662K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award, totaling $594,823, was provided by the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353). The grant's objective is to determine the role of social determinants of health (structural racism and socioeconomic position) on cardiovascular disease (CVD) outcomes among a cohort of 8,000 adults with cancer. The award will leverage data from the Reasons for Geographic and Racial Disparities in Stroke...
This five-year Project Grant award of $1,027,816 from the National Cancer Institute under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) supports research to examine the impact of structural racism on mutational signatures and outcomes in African American patients with non-small cell lung cancer (NSCLC). The research aims to: Determine how exposure to structural racism factors like air pollution and residential segregation are linked to differences in the types and...
The National Cancer Institute (NCI) awarded a $362,050 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the University of Alabama at Birmingham (UAB) to conduct an integrated genomic and transcriptomic analysis of pancreatic adenocarcinoma (PDAC) tumors from African American (AA) patients. The goal is to identify genetic and molecular mechanisms underlying the disparities in PDAC incidence and outcomes between AA and Caucasian patients. Under this grant, UAB will perform...
This $576,659 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research to investigate tumor and host immune signatures associated with health disparities in outcomes following immunotherapy for pediatric neuroblastoma. The overarching goal is to utilize biological samples from a Children's Oncology Group clinical trial to perform tumor microenvironment and host immune analyses across patients, with a focus on identifying markers that...
This federal Project Grant award in the amount of $1,165,096.00 was provided by the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353). The grant will fund a 5-year research study titled "SOCIAL GENOMIC MECHANISMS LINKING STRUCTURAL RACISM, PERCEIVED DISCRIMINATION, AND BREAST CANCER SURVIVAL" conducted by the Sloan-Kettering Institute for Cancer Research. The key objectives of the study are to: 1) Define the...
This Project Grant award, provided by the National Cancer Institute under the Cancer Biology Research (CFDA 93.396) program, aims to investigate the biological mechanisms driving racial disparities in outcomes for head and neck cancer, particularly among Black patients. The $714,062 award will fund two main objectives over a period of 5 years: Developing a tailored RNA prognostic model to enhance survival predictions for early-stage oral cancer in Black populations, by identifying gene...
This Project Grant award from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot (CFDA 93.353) program will fund a $589,591 research project to investigate factors contributing to inferior survival outcomes for Black and Hispanic patients with Hodgkin lymphoma (HL). The 5-year project, running from February 2025 to January 2030, will be conducted by the University of Florida. The research aims to: Examine differences in receipt and quality of HL...
This $466,370 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) aims to investigate racial disparities in lung cancer treatment and survival among Black non-small cell lung cancer (NSCLC) patients. The primary objectives are to: 1) Determine racial differences in receipt of cancer treatments, time to first treatment, number of treatment cycles, and dose intensity for NSCLC patients; 2) Assess the...
This federal Project Grant award, provided by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research), supports a research project titled "Trajectory of Epigenetic Aging and Health Outcomes in Childhood Cancer Survivors". The primary objectives are to: 1) examine the impact of health behaviors and social determinants of health on the rate of change in epigenetic age acceleration in childhood cancer survivors; 2) evaluate the association between the rate of...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $509,510.00 to the University of Alabama at Birmingham to conduct research on the role of disadvantage, mutational signatures, and T cell immunity in the excess risk of monoclonal gammopathy of undetermined significance (MGUS) observed in African American populations. The key objectives are to: 1) determine the influence of disadvantage on the excess MGUS risk in...